| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 77191-36-7 | 奈非西坦; N-(2,6-二甲基苯基)-2-氧代-1-吡咯烷乙酰胺 | Nefiracetam; N-(2,6-Dimethylphenyl)-2-oxo-1-pyrrolidineacetamide |  | C14H18N2O2 | 詳情 | 供應(yīng)商 |
| 88069-49-2 | 鹽酸吡西卡呢; N-(2,6-二甲基苯基)-2-(1,2,3,5,6,7-六氫吡咯烷嗪-8-基)乙酰胺鹽酸鹽 | Pilsicainide hydrochloride; N-(2,6-Dimethylphenyl)-2-(1,2,3,5,6,7-hexahydropyrrolizin-8-yl)acetamide hydrochloride |  | C17H24N2O.HCl | 詳情 | 供應(yīng)商 |
| 134002-25-8 | 3-(S)-(1-氨基甲酰-1,1-二苯基甲基)吡咯烷; (S)-alpha,alphal-二苯基-3-吡咯烷乙酰胺 | 3-(S)-(1-Carbamoyl-1,1-diphenylmethyl)pyrrolidine; (S)-alpha,alphal-Diphenyl-3-pyrrolidineacetamide |  | C18H20N2O | 詳情 | 供應(yīng)商 |
| 135463-81-9 | 考拉西坦; N-(2,3-二甲基-5,6,7,8-四氫呋喃并[2,3-b]喹啉-4-基)-2-(2-氧代吡咯烷-1-基)乙酰胺 | 1-Pyrrolidineacetamide,2-oxo-N-(5,6,7,8-tetrahydro-2,3-dimethylfuro[2,3-b]quinolin-4-yl)-; Furo[2,3-b]quinoline,1-pyrrolidineacetamide deriv.; Coluracetam; MKC 231 |  | C19H23N3O3 | 詳情 | 供應(yīng)商 |
| 27048-01-7 | 3-(2-碘代乙酰胺基)-2,2,5,5-四甲基-1-吡咯烷基自由基 | 1-Pyrrolidinyloxy,3-[(2-iodoacetyl)amino]-2,2,5,5-tetramethyl-; 1-Pyrrolidinyloxy,3-(2-iodoacetamido)-2,2,5,5-tetramethyl- (8CI); 1-Pyrrolidinyloxy, 3-[(iodoacetyl)amino]-2,2,5,5-tetramethyl-(9CI); 3-(2-Iodoacetamido)-2,2,5,5-tetramethyl-1-pyrrolidinyloxyl; 3-(2'-Iodoacetamido)-2,2,5,5-tetramethyl-1-pyrrolidinyl-1-oxyl |  | C10H18IN2O2* | 詳情 | 供應(yīng)商 |
| 100900-13-8 | 3-2-(2-溴乙酰氨基)乙酰胺]-2,2,5,5-四甲基-1-吡咯烷基氧化物; (S)-4-溴-alpha-甲基芐醇; (S)-4-溴-ALPHA-甲? | 1-Pyrrolidinyloxy,3-[[[(bromoacetyl)amino]acetyl]amino]-2,2,5,5-tetramethyl- (9CI); 3-[2-(2-Bromoacetamido)acetamide]-PROXYL; 3-[2-(2-BROMOACETAMIDO)ACETAMIDE]-PROXYL, FREE RADICAL; 3-[2-(2-BROMOACETAMIDO)ACETAMIDO]-2,2,5,5-TETRAMETHYL-1-PYRROLIDINOXY; 3-[2-(2-BROMOACETAMIDO)ACETAMIDO]-PROXYL; 3-(2-(2-BROMOACETAMIDO)ACETAMIDO)-PROXYL FREE RADICAL; 3-(2-(2-BROMOACETAMIDO)ACETAMIDO)-PROXYL FREE RADICAL 98%; 3-[2-(2-BROMOACETAMIDO)ACETAMIDE]-PROXYL, 98%, FREE RADICAL |  | C12H21BrN3O3* | 詳情 | 供應(yīng)商 |
| 17932-40-0 | 3-(2-溴乙酰胺基)-四甲基-1-吡咯烷基氧化物 | 1-Pyrrolidinyloxy,3-[(bromoacetyl)amino]-2,2,5,5-tetramethyl- (9CI); 1-Pyrrolidinyloxy,3-(2-bromoacetamido)-2,2,5,5-tetramethyl- (8CI); 3-(2-Bromoacetamido)-2,2,5,5-tetramethylpyrrolidine-1-oxyl; 3-(2-Bromoacetamido)-2,2,5,5-tetramethylpyrrolidinyloxyl; 3-Bromoacetamido-2,2,5,5-tetramethylpyrrolidin-1-oxyl; N-(1-Oxyl-2,2,5,5-tetramethyl-3-pyrroliidinyl)bromoacetamide |  | C10H18BrN2O2* | 詳情 | 供應(yīng)商 |
| 96744-75-1 | (+)-(5Α,7Α,8Β)-N-甲基-N-[7-(1-吡咯烷基)-1-氧螺[4.5]十二-8-基]-苯乙酰胺 | U-69593; U-69593; (+)-(5ALPHA,7ALPHA,8BETA)-N-METHYL-N-[7-(1-PYRROLIDINYL)-1-OXASPIRO[4.5]DEC-8-YL]-BENZENEACETAMIDE; (5ALPHA,7ALPHA,8BETA)-(+)-N-METHYL-N-(7-[1-PYRROLIDINYL]-1-OXASPIRO[4.5]DEC-8-YL)-BENZENEACETAMIDE; U-69593 SELECTIVE K OPIOID AG; (5A,7A,8B)-(-)-N-METHYL-(7-(1-PYRROLIDINYL)-1-OXASPIRO (4.5)DEC-8- YL)BENZENEACETAMIDE); U69593, (+)-(5α,7α,8β)-N-Methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]-benzeneacetamide; Benzeneacetamide, N-methyl-N-((5R,7S,8S)-7-(1-pyrrolidinyl)-1-oxaspiro(4.5)dec-8-yl)-; Benzeneacetamide, N-methyl-N-(7-(1-pyrrolidinyl)-1-oxaspiro(4.5)dec-8-yl)-, (5alpha,7alpha,8beta)-(-)- |  | C22H32N2O2 | 詳情 | 供應(yīng)商 |